Rchr
J-GLOBAL ID:201001080834232220
Update date: Feb. 24, 2025 Kato Takuya
カトウ タクヤ | Kato Takuya
Affiliation and department: Job title:
Associate Professor
Research field (2):
Cell biology
, Experimental pathology
Research theme for competitive and other funds (8): - 2023 - 2026 Connexin 43 dependent mechanism for elimination of cancer cells from epithelial layer
- 2020 - 2023 癌抑制性CAFに対する膵癌細胞の生存戦略の解明
- 2019 - 2020 Mechanism of determining the invasive pattern of SCC
- 2014 - 2016 Molecular Mechanisms of Collective Migration of Cancer Cells
- 2013 - 2015 Regulatory mechanism of p53 deubiquitinating enzyme USP7
- 2012 - 2014 Mechanism of chemoresistance by HDAC1-associating protein and development of molecular targeted therapy
- 2011 - 2012 Molecular mechanism for collective invasion of cancer cell groups
- 2009 - 2010 Analysis of the regulatory mechanism of Lamin A degradation by RFP and its significance in malignant transformation.
Show all
Papers (56): -
Yurika Kesen, Masaaki Ichinoe, Shoko Hayashi, Atsuko Umezawa, Yoshiko Numata, Taro Kogami, Masahiro Matsushita, Itaru Sanoyama, Akiyoshi Hoshino, Yasutaka Sakurai, et al. High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma. Pathology international. 2024
-
Shoko Hayashi, Masaaki Ichinoe, Yasutaka Sakurai, Yurika Kesen, Takuya Kato, Itaru Sanoyama, Akiyoshi Hoshino, Kazu Shiomi, Masashi Mikubo, Yukitoshi Satoh, et al. Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity. Pathology, research and practice. 2024. 266. 155779-155779
-
村雲 芳樹, 櫻井 靖高, 星野 昭芳, 加藤 琢哉, 一戸 昌明. 癌治療における損傷乗り越えDNA複製蛋白REV7の有用性(Potential usage of translesion DNA synthesis protein REV7 in cancer therapy). 日本癌学会総会記事. 2024. 83回. E-3036
-
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, et al. REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science. 2024. 115. 2. 660-671
-
Yuko Shimada, Takuya Kato, Yasutaka Sakurai, Hitoe Watanabe, Mayu Nonaka, Natsumi Nanaura, Masaaki Ichinoe, Yoshiki Murakumo. Identification of the promoter region regulating the transcription of the REV7 gene. Biochemical and biophysical research communications. 2023. 662. 8-17
more... MISC (15): -
Masaki Hirano, Melissa Ranjit, Akane Yamamichi, Kosuke Aoki, Fumiharu Ohka, Takuya Kato, Atsushi Enomoto, Masahide Takahashi, Toshihiko Wakabayashi, Atsushi Natsume. ABERRANT SUPER-ENHANCERS ASSOCIATED WITH DOWNREGULATION OF RET FINGER PROTEIN OVERCOMES CHEMORESISTANCE IN GLIOBLASTOMA. NEURO-ONCOLOGY. 2017. 19. 103-103
-
平野 雅規, ランジット・メリッサ, 山道 茜, 青木 恒介, 大岡 史治, 加藤 琢哉, 榎本 篤, 高橋 雅英, 若林 俊彦, 夏目 敦至. RET finger proteinの発現抑制に関連したsuper-enhancer異常によりglioblastomaの化学療法抵抗性が改善される. 日本癌学会総会記事. 2017. 76回. J-2064
-
Yoshiki Murakumo, Naoki Watanabe, Shinji Mii, Masato Asai, Naoya Asai, Kaoru Niimi, Takuya Kato, Atsushi Enomoto, Masahide Takahashi. DNA repair protein Rev7 is required for primordial germ cell maintenance in the mouse. CANCER RESEARCH. 2014. 74. 19
-
Yoshihisa Sugimura, Shintaro Iwama, Atsushi Kiyota, Hiroshi Takagi, Seiji Takeuchi, Hisakazu Izumida, Takuya Kato, Atsushi Enomoto, Yutaka Oiso. Identification of a novel autoantigen and a diagnostic marker of autoimmune hypophysitis. JOURNAL OF NEUROIMMUNOLOGY. 2012. 253. 1-2. 23-24
-
Kei Ohara, Atsushi Enomoto, Takuya Kato, Takahiko Hashimoto, Mayu Isotani-Sakakibara, Naoya Asai, Maki Ishida-Takagishi, Liang Weng, Masanori Nakayama, Takashi Watanabe, et al. Involvement of Girdin in the Determination of Cell Polarity during Cell Migration. PLOS ONE. 2012. 7. 5. e36681
more... Patents (6): Education (2): - 2006 - 2009 Nagoya University Doctor Course, Graduate School of Medicine
- 2004 - 2006 Nagoya University Master Course, Graduate School of Medicine
Work history (9): - 2024/04 - 現在 Fujita Health University Department of Molecular Pathology, School of Medicine Associate Professor
- 2023/03 - 2024/03 Kitasato University
- 2018/05 - 2023/02 Kitasato University School of Medicine Department of Pathology Assistant Professor
- 2016/05 - 2018/04 The Francis Crick Institute Tumour Cell Biology Project Research Scientist (Marie Skłodowska-Curie Actions Research Fellow)
- 2015/04 - 2016/04 The Francis Crick Institute Tumour Cell Biology Visiting Scientist
- 2014/10 - 2015/03 Cancer Research UK London Research Institute Tumour Cell Biology Visiting Scientist
- 2013/05 - 2014/09 Nagoya University Graduate School of Medicine Department of Pathology Assistant Professor
- 2009/05 - 2013/04 Nagoya University Graduate School of Medicine Department of Pathology Assistant Professor
- 2009/04 - 2009/04 Nagoya University Graduate School of Medicine Department of Pathology Visiting Researcher
Show all
Return to Previous Page